devdiscourse17m
FDA Declares No Shortage of Popular Weight-Loss Drugs Wegovy and Ozempic
The FDA declared the end of the shortage of Novo Nordisk’s Wegovy and Ozempic, impacting compounding pharmacies selling ...
Novo’s Ozempic Shortage Is Declared Over, Hitting Copycat Makers
Novo Nordisk A/S’s weight-loss and diabetes drugs are no longer in short supply, US regulators said, a decision that’s expected to curtail widespread access to cheaper copies of the popular ...
European shares end week near record highs
European shares settled near a record high on Friday and marked their longest streak of weekly gains in nearly a year, The ...
The Ozempic shortage is over, a big threat to off-brand weight loss drug sellers
The shortage of Novo Nordisk’s (NVO) blockbuster diabetes and weight-loss drugs is officially over, according to the U.S.
Yearslong shortage of Ozempic and Wegovy in U.S. resolved, FDA says
In December, the FDA declared that shortages of treatments Zepbound and Mounjaro from another drugmaker, Eli Lilly and Co., ...
Why Novo Nordisk Stock Popped on Friday
Detailed price information for Novo Nordisk A/S ADR (NVO-N) from The Globe and Mail including charting and trades.